Ignite Creation Date:
2024-05-05 @ 10:41 PM
Last Modification Date:
2024-10-26 @ 10:22 AM
Study NCT ID:
NCT01162785
Status:
COMPLETED
Last Update Posted:
2016-11-28
First Post:
2010-07-13
Brief Title:
1B Intravesical Administration of SCH 721015 Ad-IFNa in Admixture With SCH 209702 Syn3 for The Treatment of BCG Refractory Superficial Bladder Cancer
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Organization Data
Organization:
MD Anderson Cancer Center
Class:
OTHER
Study ID:
2009-0938
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MD Anderson Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| FKD Therapies Oy of Finland | UNKNOWN |